Press Release
H&R GmbH & Co. KGaA confirms preliminary figures for Q1-2025
- Solid start into the year with slight improvements for sales revenues and earnings
- Performance of segment REFINING pushes EBITDA over previous year’s level
Salzbergen, Germany, May 15, 2025. H&R GmbH & Co. KGaA (in short: H&R KGaA; ISIN DE000A2E4T77) has confirmed the preliminary key figures for the start of the year. The company reported operative earnings (EBITDA - consolidated earnings before taxes on income and earnings, other financing income and expenses and depreciation, amortization and write-ups on intangible assets and property, plant and equipment) of EUR 22.4 million in the first quarter of 2025 (same period in the previous year: EUR 21.3 million). The past quarter delivered higher sales revenues of EUR 345.8 million (Q1-2024: EUR 337.0 million).
Key Figures for H&R KGaA:
in € million |
Q1-2025 |
Q1-2024 |
- / + |
|
|
|
|
Sales revenues |
345.8 |
337.0 |
8.8 |
Operative Earnings (EBITDA) |
22.4 |
21.3 |
1.1 |
EBIT |
7.7 |
6.8 |
0.9 |
Earnings before Income Taxes |
4.7 |
3.6 |
1.1 |
Net Profit attributable to Shareholders |
1.9 |
1.5 |
0.4 |
Earnings per Share (€) |
0.05 |
0.04 |
0.01 |
Operating Cash flow |
-8.1 |
11.4 |
-19.5 |
Free Cash flow |
-17.7 |
-0.2 |
-17.5 |
|
|
|
|
|
31/3/25 |
31/12/24 |
- / + |
Balance Sheet Total |
1,011.4 |
1,014.8 |
-3.4 |
Equity |
466.0 |
468.6 |
-2.6 |
Equity Ratio (in%) |
46.1 |
46.2 |
-0.1 |
Key Figures for segments
in Mio. € |
Q1-2025 |
Q1-2024 |
- / + |
|
|
|
|
Sales revenues |
|
|
|
ChemPharm Refining |
217.4 |
206.4 |
11.0 |
ChemPharm Sales |
123.7 |
122.9 |
0.8 |
Plastics |
9.6 |
12.3 |
-2.7 |
Reconciliation |
-4.9 |
-4.6 |
-0.3 |
|
|
|
|
EBITDA |
|
|
|
ChemPharm Refining |
13.9 |
10.5 |
3.4 |
ChemPharm Sales |
9.7 |
10.9 |
-1.2 |
Plastics |
-0.4 |
0.4 |
-0.8 |
Reconciliation |
-0.9 |
-0.5 |
-0.4 |
For more detailed statements on the business and earnings development, especially the 2025 full-year expectations, the company refers to the quarterly statement for the first quarter of 2025 published today, which is available for download at www.hur.com in the \"Investor Relations\" section.
Contact information:
H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser
Neuenkirchener Strasse 8, 48499 Salzbergen
Tel.: +49 40 43218-321, Fax: +49 40 43218-390
e-mail: ties.kaiser@hur.com ; www.hur.com
H&R GmbH & Co. KGaA:
H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.
Forward-looking statements and forecasts:
This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.